Itolizumab, used in the treatment of corona / skin treatment with psoriasis medicine, has been given conditional approval for covid, will be given in case of shortness of breath
The patient must be informed before using the injection
Pulmonologist, pharmacologist and AIIMS medicine expert were included in the trial panel
The Drug Controller General of India (DCGI) has approved the conditional use of itolizumab injection for the treatment of coronavirus, a skin related disease (psoriasis). It will be used on patients who are suffering from medical term ARDS after being infected. This condition can also cause respiratory problems.
What a benefit
Drug regulator Dr VG Somani on Friday approved the use of the injection. That is, it can now be used in the treatment of Kovid-19 patients. LRDS patients have problems with the lungs. It causes difficulty breathing and often severe inflammation. Itolizumab injections are manufactured by Biocon Limited. It is used in the treatment of plague or psoriasis. It was approved only last year.
Also read
Divaybhskr news
Will prove effective in India
A DCGI official told the news agency that a trial of its injection was conducted on Kovid-19 patients in India. The results have been good. Our team consisted of pulmonologists, pharmacologists and medical experts from AIIMS. However, doctors must inform the patient before using it. It also requires his approval.
Such an epidemic does not occur in any country and we have to fight against this epidemic and face it and follow the rules of the government. Avoid Corona and help the people in this epidemic.
You will find the same news here and here we will give you the information of government job and here you will get all the information about where to fill the form in the information of this government job.
The patient must be informed before using the injection
Pulmonologist, pharmacologist and AIIMS medicine expert were included in the trial panel
The Drug Controller General of India (DCGI) has approved the conditional use of itolizumab injection for the treatment of coronavirus, a skin related disease (psoriasis). It will be used on patients who are suffering from medical term ARDS after being infected. This condition can also cause respiratory problems.
What a benefit
Drug regulator Dr VG Somani on Friday approved the use of the injection. That is, it can now be used in the treatment of Kovid-19 patients. LRDS patients have problems with the lungs. It causes difficulty breathing and often severe inflammation. Itolizumab injections are manufactured by Biocon Limited. It is used in the treatment of plague or psoriasis. It was approved only last year.
Also read
Divaybhskr news
Will prove effective in India
A DCGI official told the news agency that a trial of its injection was conducted on Kovid-19 patients in India. The results have been good. Our team consisted of pulmonologists, pharmacologists and medical experts from AIIMS. However, doctors must inform the patient before using it. It also requires his approval.
Such an epidemic does not occur in any country and we have to fight against this epidemic and face it and follow the rules of the government. Avoid Corona and help the people in this epidemic.
You will find the same news here and here we will give you the information of government job and here you will get all the information about where to fill the form in the information of this government job.
No comments:
Post a Comment